tiprankstipranks
Trending News
More News >
Aemetis (AMTX)
NASDAQ:AMTX
Advertisement

Aemetis (AMTX) AI Stock Analysis

Compare
1,113 Followers

Top Page

AMTX

Aemetis

(NASDAQ:AMTX)

Rating:58Neutral
Price Target:
$3.50
▲(7.36%Upside)
Aemetis's overall stock score reflects serious financial challenges and a negative valuation outlook, but technical indicators and future growth prospects provide some optimism. The company's strategic initiatives in renewable sectors and potential benefits from regulatory support are positive, yet overshadowed by current financial instability.
Positive Factors
Growth Potential
Aemetis has a strong 5-year financial plan aiming to reach $1 billion in revenue by 2026, indicating confidence in significant growth potential.
Investment Approval
Approval for $200 million of EB-5 program investment for multiple sustainable projects, including the Riverbank SAF production plant and the dairy RNG project.
Project Development
The company is making good progress on its key biogas and cellulosic ethanol production facility projects.
Negative Factors
Earnings Miss
Q1 revenue was $43 million, compared to estimates of $50 million and consensus of $59 million, indicating weaker than expected performance.
Revenue Decline
Aemetis reported its fiscal Q4 2024 revenue at $47 million, which was significantly lower than the previous year and below both analyst estimates and consensus expectations.
Tax Credit Uncertainty
Realizing Inflation Reduction Act (IRA) 45Z Production Tax Credits (PTC) in 2025 is partly dependent on the IRS releasing the calculation guideline for RNG, with limited clarity on the timeline.

Aemetis (AMTX) vs. SPDR S&P 500 ETF (SPY)

Aemetis Business Overview & Revenue Model

Company DescriptionAemetis, Inc. (NASDAQ: AMTX) is a renewable fuels and biochemical company focused on the production and commercialization of sustainable products that replace traditional petroleum-based fuels and chemicals. Operating in the biofuels and renewable energy sectors, Aemetis is engaged in producing ethanol, biodiesel, and renewable jet and diesel fuels, along with biogas and high-value chemicals derived from renewable resources. The company's core products are aimed at reducing carbon emissions and promoting cleaner energy alternatives to address global environmental challenges.
How the Company Makes MoneyAemetis generates revenue primarily through the sale of renewable fuels and biochemicals. The company's key revenue streams include the production and sale of ethanol at its California-based biofuel plant, which contributes significantly to its earnings. Additionally, Aemetis sells biodiesel and renewable jet fuel produced at its facilities in India and the United States. Revenue is further bolstered by the company's focus on carbon reduction initiatives, including the production of dairy biogas, which is sold as renewable natural gas under California's Low Carbon Fuel Standard (LCFS) and the federal Renewable Fuel Standard (RFS). Strategic partnerships and government incentives for renewable energy projects also play a crucial role in supporting Aemetis's revenue model, providing both financial support and market access for their sustainable products.

Aemetis Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q1-2025)
|
% Change Since: 150.77%|
Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a mix of challenges and positive developments. The company faces significant revenue decline and net losses but is also making strategic investments and progressing in key areas like RNG and ethanol production. The resumption of biodiesel contracts in India and upcoming IPO plans are promising, while regulatory and financial support provides a solid foundation for future growth.
Q1-2025 Updates
Positive Updates
Resumption of Biodiesel Contracts in India
Biodiesel shipments to government oil marketing companies in India resumed in April after a six-month pause, indicating a recovery in revenues from this segment.
RNG Production and Revenue Growth
RNG volumes increased by 17% year over year. The company is scaling gas production rapidly with expectations to reach 550,000 MMBtus of production capacity this year and grow to 1,000,000 MMBtu annually by 2026.
Ethanol Plant Upgrades and Cost Reductions
Off-site construction of a $30 million mechanical vapor recompression system at the Keyes ethanol plant is underway, expected to reduce natural gas use by 80% and add an estimated $32 million in annual cash flow starting in 2026.
Strong Financial and Regulatory Support
Secured $20 million in grants and tax credits for the ethanol system upgrade, with additional revenues expected from LCFS credits, federal tax incentives, and investment tax credits.
IPO Plans for India Subsidiary
Aemetis is preparing for an IPO of its India subsidiary, targeting late 2025 or early 2026, which is expected to bring in significant cash and support expansion into RNG and ethanol production in India.
Negative Updates
Significant Revenue Decline
Revenues dropped to $42.9 million from $72.6 million in the previous year, primarily due to delayed biodiesel contracts in India.
Operating and Net Losses
The company reported an operating loss of $15.6 million and a net loss of $24.5 million, roughly flat versus Q1 last year, with increased SG&A costs contributing to the operating loss.
Cash and Debt Position
Cash at the end of the quarter was $500,000 following $15.4 million of debt repayment, highlighting a tight cash position despite ongoing investments.
Company Guidance
During the Aemetis, Inc. First Quarter 2025 earnings call, several key metrics and guidance were shared by the management team. Revenues for the quarter were reported at $42.9 million, a decrease from $72.6 million the previous year, primarily due to delayed biodiesel contracts in India, which have resumed and are expected to boost Q2 revenues. The company saw a $1.7 million revenue increase at its Keyes ethanol plant due to stronger pricing, and RNG volumes rose by 17% year-over-year. Despite an operating loss of $15.6 million, largely attributed to a $1.6 million increase in SG&A costs, the company anticipates revenue growth from multiple streams, including LCFS credits, federal tax incentives, and resumed biodiesel shipments in India. Aemetis expects to reach 550,000 MMBtus of dairy RNG production capacity this year, with plans to expand to 1,000,000 MMBtus annually by 2026. Additionally, the company is advancing projects in sustainable aviation fuel and carbon capture, supported by regulatory tailwinds and policy developments. Looking ahead, Aemetis is poised for growth and improved cash flow in the latter half of 2025, driven by strategic investments, tax credit monetization, and policy support.

Aemetis Financial Statement Overview

Summary
Aemetis faces severe financial challenges, including negative profitability, high leverage, and negative cash flows across all financial metrics. The income statement, balance sheet, and cash flow statement scores are all very low, reflecting these issues.
Income Statement
15
Very Negative
Aemetis has faced significant challenges in profitability and revenue growth. The TTM gross profit margin remains negative, indicating struggles with cost management. There is a notable negative trend in net profit margin and EBIT margin, highlighting ongoing losses. Revenue growth has been inconsistent, with recent periods showing a decline.
Balance Sheet
12
Very Negative
The balance sheet shows a high debt burden with negative stockholders' equity, reflecting financial instability and potential solvency concerns. The debt-to-equity ratio is unfavorable due to negative equity, and the equity ratio is negative, demonstrating an over-leveraged position.
Cash Flow
20
Very Negative
Cash flow metrics indicate severe challenges in generating positive cash flow. The TTM operating cash flow is negative, and free cash flow remains negative, highlighting liquidity issues. The free cash flow to net income ratio is concerning, suggesting poor cash conversion.
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Aemetis Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.26
Price Trends
50DMA
2.36
Positive
100DMA
1.98
Positive
200DMA
2.40
Positive
Market Momentum
MACD
0.24
Positive
RSI
64.73
Neutral
STOCH
79.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMTX, the sentiment is Positive. The current price of 3.26 is above the 20-day moving average (MA) of 3.03, above the 50-day MA of 2.36, and above the 200-day MA of 2.40, indicating a bullish trend. The MACD of 0.24 indicates Positive momentum. The RSI at 64.73 is Neutral, neither overbought nor oversold. The STOCH value of 79.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AMTX.

Aemetis Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$1.65B3.02-4.95%-9.25%-113.66%
66
Neutral
$8.14B35.13-1.49%4.63%-11.17%-109.60%
60
Neutral
$464.06M-30.25%6.50%-151.25%
58
Neutral
$176.63M37.38%-7.51%-67.44%
51
Neutral
$1.42B-151.69%4.37%-29.23%-931.43%
49
Neutral
$2.89B268.82-27.14%9.61%-16.21%-130.18%
44
Neutral
AU$1.46B-6.99-23.02%6.34%5.33%-26.92%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMTX
Aemetis
3.26
-0.16
-4.68%
CLNE
Clean Energy Fuels
2.16
-0.51
-19.10%
CVI
CVR Energy
28.72
0.54
1.92%
DK
Delek US Holdings
23.35
0.80
3.55%
DINO
HF Sinclair Corporation
44.98
-3.91
-8.00%
PARR
Par Pacific Holdings
32.05
5.88
22.47%

Aemetis Corporate Events

Executive/Board ChangesShareholder Meetings
Aemetis Announces Director Elections and Key Approvals
Neutral
May 16, 2025

At its Annual Meeting of Stockholders on May 14, 2025, Aemetis, Inc. announced the election of Eric A. McAfee and Francis P. Barton as Class I directors, who will serve until the 2028 annual meeting. Additionally, the appointment of RSM US LLP as the independent registered public accounting firm for 2025 was ratified, and the compensation of the Company’s Named Executive Officers was approved on an advisory basis with 83% support.

The most recent analyst rating on (AMTX) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Aemetis stock, see the AMTX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025